Cargando…

The NLRP3 inflammasome: a new player in neurological diseases

Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so...

Descripción completa

Detalles Bibliográficos
Autores principales: EREN, Elif, ÖZÖREN, Nesrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911260/
https://www.ncbi.nlm.nih.gov/pubmed/31892810
http://dx.doi.org/10.3906/biy-1909-31
_version_ 1783479231300239360
author EREN, Elif
ÖZÖREN, Nesrin
author_facet EREN, Elif
ÖZÖREN, Nesrin
author_sort EREN, Elif
collection PubMed
description Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so far, NLRP3 is of main interest since mutations in Nlrp3 gene are associated with autoinflammatory diseases such as Muckle–Wells syndrome, neonatal onset multisystem inflammatory disease, and familial cold urticaria/autoinflammatory syndrome. On the other hand, whereas other inflammasomes are mainly detectors of specific molecular motifs, NLRP3 is acting as a general sensor of cellular perturbations including potassium efflux, lysosomal damage, and ROS production. Besides this central role of NLRP3 in inflammation, recent publications show that the NLRP3 inflammasome is also involved in the physiopathology of several neurological disorders including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. This review gives an overview of the established functions of the NLRP3 inflammasome in mediating inflammation in macrophages and describes its recently discovered roles in neurological disorders in promoting neuroinflammation, as well as modulating key proteins mediating the disorders. Finally, we discuss the targeting of NLRP3 in neurological diseases and present some examples of NLRP3 inhibitors that could be used in neurological disorder treatments.
format Online
Article
Text
id pubmed-6911260
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-69112602019-12-31 The NLRP3 inflammasome: a new player in neurological diseases EREN, Elif ÖZÖREN, Nesrin Turk J Biol Article Inflammasomes are supramolecular protein complexes implicated in the detection of pathogens or danger-associated molecules and are responsible for mounting the first line of innate immune response to counteract these signals and restore tissue homeostasis. Among different inflammasomes identified so far, NLRP3 is of main interest since mutations in Nlrp3 gene are associated with autoinflammatory diseases such as Muckle–Wells syndrome, neonatal onset multisystem inflammatory disease, and familial cold urticaria/autoinflammatory syndrome. On the other hand, whereas other inflammasomes are mainly detectors of specific molecular motifs, NLRP3 is acting as a general sensor of cellular perturbations including potassium efflux, lysosomal damage, and ROS production. Besides this central role of NLRP3 in inflammation, recent publications show that the NLRP3 inflammasome is also involved in the physiopathology of several neurological disorders including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. This review gives an overview of the established functions of the NLRP3 inflammasome in mediating inflammation in macrophages and describes its recently discovered roles in neurological disorders in promoting neuroinflammation, as well as modulating key proteins mediating the disorders. Finally, we discuss the targeting of NLRP3 in neurological diseases and present some examples of NLRP3 inhibitors that could be used in neurological disorder treatments. The Scientific and Technological Research Council of Turkey 2019-12-13 /pmc/articles/PMC6911260/ /pubmed/31892810 http://dx.doi.org/10.3906/biy-1909-31 Text en Copyright © 2019 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
EREN, Elif
ÖZÖREN, Nesrin
The NLRP3 inflammasome: a new player in neurological diseases
title The NLRP3 inflammasome: a new player in neurological diseases
title_full The NLRP3 inflammasome: a new player in neurological diseases
title_fullStr The NLRP3 inflammasome: a new player in neurological diseases
title_full_unstemmed The NLRP3 inflammasome: a new player in neurological diseases
title_short The NLRP3 inflammasome: a new player in neurological diseases
title_sort nlrp3 inflammasome: a new player in neurological diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911260/
https://www.ncbi.nlm.nih.gov/pubmed/31892810
http://dx.doi.org/10.3906/biy-1909-31
work_keys_str_mv AT erenelif thenlrp3inflammasomeanewplayerinneurologicaldiseases
AT ozorennesrin thenlrp3inflammasomeanewplayerinneurologicaldiseases
AT erenelif nlrp3inflammasomeanewplayerinneurologicaldiseases
AT ozorennesrin nlrp3inflammasomeanewplayerinneurologicaldiseases